News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News Charity raises funds for legal fight over HIV drug National AIDS Trust continues legal battle over Truvada.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
